These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group. Li H; Sisoudiya SD; Martin-Giacalone BA; Khayat MM; Dugan-Perez S; Marquez-Do DA; Scheurer ME; Muzny D; Boerwinkle E; Gibbs RA; Chi YY; Barkauskas DA; Lo T; Hall D; Stewart DR; Schiffman JD; Skapek SX; Hawkins DS; Plon SE; Sabo A; Lupo PJ J Natl Cancer Inst; 2021 Jul; 113(7):875-883. PubMed ID: 33372952 [TBL] [Abstract][Full Text] [Related]
4. Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experience. Pondrom M; Bougeard G; Karanian M; Bonneau-Lagacherie J; Boulanger C; Boutroux H; Briandet C; Chevreau C; Corradini N; Coze C; Defachelles AS; Galmiche-Roland L; Orbach D; Piguet C; Scoazec JY; Vérité C; Willems M; Frebourg T; Minard V; Brugières L Pediatr Blood Cancer; 2020 Sep; 67(9):e28486. PubMed ID: 32658383 [TBL] [Abstract][Full Text] [Related]
5. Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis. Batalini F; Peacock EG; Stobie L; Robertson A; Garber J; Weitzel JN; Tung NM Breast Cancer Res; 2019 Sep; 21(1):107. PubMed ID: 31533767 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis. Kratz CP; Freycon C; Maxwell KN; Nichols KE; Schiffman JD; Evans DG; Achatz MI; Savage SA; Weitzel JN; Garber JE; Hainaut P; Malkin D JAMA Oncol; 2021 Dec; 7(12):1800-1805. PubMed ID: 34709361 [TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of anaplasia in childhood rhabdomyosarcoma: A report from the Children's Oncology Group. Shenoy A; Alvarez E; Chi YY; Li M; Shern JF; Khan J; Hiniker SM; Granberg CF; Hawkins DS; Parham DM; Teot LA; Rudzinski ER Eur J Cancer; 2021 Jan; 143():127-133. PubMed ID: 33302115 [TBL] [Abstract][Full Text] [Related]
8. Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study. de Andrade KC; Khincha PP; Hatton JN; Frone MN; Wegman-Ostrosky T; Mai PL; Best AF; Savage SA Lancet Oncol; 2021 Dec; 22(12):1787-1798. PubMed ID: 34780712 [TBL] [Abstract][Full Text] [Related]
9. The role of TP53 pathogenic variants in early-onset HER2-positive breast cancer. Escudeiro C; Pinto C; Vieira J; Peixoto A; Pinto P; Pinheiro M; Santos C; Guerra J; Lisboa S; Santos R; Silva J; Leal C; Coimbra N; Lopes P; Ferreira M; Sousa AB; Teixeira MR Fam Cancer; 2021 Jul; 20(3):173-180. PubMed ID: 33051812 [TBL] [Abstract][Full Text] [Related]
10. TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children. Qian M; Cao X; Devidas M; Yang W; Cheng C; Dai Y; Carroll A; Heerema NA; Zhang H; Moriyama T; Gastier-Foster JM; Xu H; Raetz E; Larsen E; Winick N; Bowman WP; Martin PL; Mardis ER; Fulton R; Zambetti G; Borowitz M; Wood B; Nichols KE; Carroll WL; Pui CH; Mullighan CG; Evans WE; Hunger SP; Relling MV; Loh ML; Yang JJ J Clin Oncol; 2018 Feb; 36(6):591-599. PubMed ID: 29300620 [TBL] [Abstract][Full Text] [Related]
11. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S; JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity. Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of TP53 germline variants and their correlations with Li-Fraumeni syndrome or Li-Fraumeni-like syndrome in Chinese tumor patients. Tian P; Zhang X; Yang S; Fang Y; Yuan H; Li W; Zhu H; Zhao F; Ding J; Zhu Y; Wang S; Sun G; Ni H; Ma T; Lei T J Genet Genomics; 2022 Jul; 49(7):645-653. PubMed ID: 35033608 [TBL] [Abstract][Full Text] [Related]
15. Variable population prevalence estimates of germline TP53 variants: A gnomAD-based analysis. de Andrade KC; Frone MN; Wegman-Ostrosky T; Khincha PP; Kim J; Amadou A; Santiago KM; Fortes FP; Lemonnier N; Mirabello L; Stewart DR; Hainaut P; Kowalski LP; Savage SA; Achatz MI Hum Mutat; 2019 Jan; 40(1):97-105. PubMed ID: 30352134 [TBL] [Abstract][Full Text] [Related]
16. Current review of TP53 pathogenic germline variants in breast cancer patients outside Li-Fraumeni syndrome. Fortuno C; James PA; Spurdle AB Hum Mutat; 2018 Dec; 39(12):1764-1773. PubMed ID: 30240537 [TBL] [Abstract][Full Text] [Related]
17. da Silva PFF; Goveia RM; Teixeira TB; Gamba BF; de Lima AP; Rogatto SR; Silveira-Lacerda EP Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625568 [No Abstract] [Full Text] [Related]
18. Case Report: Identification of a Novel Pathogenic Germline Paduano F; Fabiani F; Colao E; Trapasso F; Perrotti N; Barbieri V; Baudi F; Iuliano R Front Genet; 2021; 12():734809. PubMed ID: 34539758 [TBL] [Abstract][Full Text] [Related]
19. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil. Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735 [TBL] [Abstract][Full Text] [Related]
20. Case Report: A Novel Pathomechanism in PEComa by the Loss of Heterozygosity of Butz H; Lövey J; Szentkereszty M; Bozsik A; Tóth E; Patócs A Front Oncol; 2022; 12():849004. PubMed ID: 35419288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]